A good time is par for the course on the occasions when the Folk Orchestra of Santa Barbara (FOSB) convenes. It’s that time ...

Annapurna Interactive and Beethoven and Dinosaur have confirmed a release date for Mixtape on Nintendo Switch 2.

More than 150 Latin music acts will be performing at the 2026 South by Southwest festival. From Big Soto to Mariangela, these ...

The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine, claiming the company had not used an appropriate control group in its pivotal ...

Dolly Parton's name might inspire full-throated sing-a-longs to her working woman's anthem “9 to 5," or evoke memories of thrilling days spent at her Dollywood theme park.

US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’ The Food and Drug Administration (FDA) reversed course on Wednesday and will ...

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...

Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the drugmaker's first flu shot of the season, reversing course on a decision to reject ...

Matthew Herper covers medical innovation — both its promise and its perils. Well, that didn’t take long. It took all of one week to go from an announcement that the Food and Drug Administration was ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...

WASHINGTON—In an hour-long meeting in January, Food and Drug Administration career staff laid out their objections to a plan to block a new flu shot from vaccine maker Moderna. They argued that ...

The US Food and Drug Administration has declined to review Moderna's approval application for its novel mRNA flu vaccine, causing a fall in the company's shares on late Tuesday. Moderna on Tuesday ...